In this episode of the Huberman Lab podcast, Andrew discusses the potential uses of peptides - small amino acid chains that can influence the body's mental, physical, and cognitive functions. Guest Craig Koniver shares insights on peptides like semaglutide and BPC-157 for weight loss, joint pain, and healing, as well as growth hormone secretagogues for muscle growth and fat loss.
The conversation also touches on compound therapies like NAD infusions, methylene blue, and glycine, exploring their effects on energy levels, cognitive performance, and sleep quality. While acknowledging the FDA's restrictions and concerns around certain peptides, Huberman and Koniver emphasize the importance of obtaining these compounds from reputable sources.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Peptides are small chains of amino acids that can influence mental, physical, and cognitive functions in the body. As Andrew Huberman mentions, they sit between basic lifestyle factors and more advanced hormone therapies, providing benefits without necessarily shutting down natural hormone production.
Craig Koniver discusses using compounded semaglutide and tirzepatide, originally diabetes drugs, to facilitate weight loss. Through microdosing and gradual increases, he aims to mitigate side effects like muscle loss while enabling steady fat loss.
BPC-157 is a highly anti-inflammatory peptide used by Koniver's patients for issues like joint pain and gut problems. Notably, Koniver says it may upregulate [restricted term] receptors, enhancing the effects of [restricted term] secretagogue peptides.
Ipamorelin, tesamorelin, and hexarelin can boost natural [restricted term] release, promoting repair, healing, muscle growth, and fat loss when injected. Koniver notes they have different "flavors," with some more focused on energy/endurance and others on fat loss.
The FDA has banned or restricted several peptides like BPC-157, CJC-1295, and thymosin alpha-1. While safety concerns exist, Huberman and Koniver suggest pharmaceutical companies' financial interests may play a role. They emphasize obtaining peptides from reputable, regulated compounding pharmacies.
Huberman and Koniver discuss the transformative effects of NAD infusions on energy levels, noting NAD's role in mitochondrial function and inflammation reduction, though exact mechanisms are unknown.
An old pharmaceutical gaining new interest, methylene blue can enhance oxygen delivery and mitochondrial efficiency, potentially improving cognitive function.
The amino acid glycine can help calm the nervous system and aid liver detoxification. Combined with peptides like pinealon, Koniver says it may improve sleep quality and recovery.
1-Page Summary
Peptides, which are small chains of amino acids, play numerous roles in the human body, influencing mental, physical, and cognitive functions.
A peptide is essentially a small protein, and our bodies contain thousands of different peptides, each with a unique function. There are about 300,000 different peptides that the body makes, and therapeutically, approximately 150 are utilized. They are simply chains of amino acids that can target and augment specific biological pathways related to various aspects of health and performance.
Andrew Huberman notes that his overall well-being—encompassing physical health, mental health, and performance—improves when he takes AG1, a nutrient mix including adaptogens. These adaptogens are often found in insufficient quantities in food alone, suggesting the importance of such compounds for foundational nutritional needs.
Peptides and related compounds offer a middle ground between solely focusing on diet and exerc ...
Overview of peptides and their uses for mental health, physical health, and performance
Craig Koniver, Andrew Huberman, and Dr. Conover delve into the therapeutic potential of various peptides such as GLP-1 agonists, BPC-157, and [restricted term] secretagogues, highlighting their unique attributes and applications.
Semaglutide and tirzepatide, as GLP-1 agonist peptides, were originally approved for glucose control in type 2 diabetes but became popular for weight loss due to observed side effects. These drugs are now FDA approved specifically for weight management and have been compounded to make them more affordable. With microdosing and gradual increases, practitioners like Koniver aim to reduce side effects like muscle loss, emphasizing the importance of protein intake and resistance training.
Craig Koniver discusses compounded semaglutide and tirzepatide, aiming to help patients lose weight at a healthy rate while mitigating side effects such as nausea through microdosing. By allowing less than two pounds loss per week, he ensures muscle mass retention along with weight loss.
BPC-157, known for its strong anti-inflammatory properties, is used widely by Koniver's patients for conditions ranging from joint pain to gastrointestinal issues. It has shown improved results with injection over oral administration due to its systemic effects. Koniver reveals that BPC-157 can be administered directly into tendons, unlike steroids, and upregulates [restricted term] receptors, enhancing the efficacy of [restricted term] secretagogues.
Koniver notes synergetic effects of BPC-157 when combined with [restricted term] secretagogues, as it makes [restricted term] receptor binding more efficient. Hence, while BPC-157 alone is beneficial for healing ligaments and tendons, its combination with [restricted term]-releasing peptides enhances its healing properties.
Koniver and Huberman explore the benefits of [restricted term] secretagogue peptides, which stimulate the body's natural ...
Specific peptides discussed, including GLP-1 agonists, BPC-157, and growth hormone secretagogues
The Food and Drug Administration (FDA) has taken action against several peptides, prompting discussions on the complexities of regulation, safety, and the pharmaceutical industry's interests.
In October of 2023, the FDA listed many peptides, such as BPC-157, on a category two list, effectively removing them from the legitimate compounding market. Additionally, peptides such as CJC-1295 and thymosin alpha-1 have faced similar bans or restrictions. Thymosin alpha-1 was widely regarded as effective for immune modulation and used in treating autoimmune diseases and long COVID, but now it has been "nuked" by the FDA. Although CJC-1295 was once banned, it and thymosin alpha-1 are again allowed for prescription.
Despite the FDA's action on certain peptides, alternatives such as Hexarelin remain available. Hexarelin does not stimulate appetite and is sometimes used in the morning to help with waking up. However, rumors suggest that the ability to compound GLP-1 peptides might be removed, leading to potentially higher costs if not covered by insurance.
After the restriction of BPC-157 by the FDA, alternatives such as pentadecapeptide are gaining attention as potential substitutes because they may offer similar benefits and are still available for compounding.
Andrew Huberman and Craig Koniver discuss the role of safety concerns and financial interests in the banning of peptides like MK677, Thymosin alpha-1, and BPC-157 by the FDA. They question whether the FDA's actions are completely in the interest of public safety or if pharmaceutical companies' desires to profit from these compounds play a part.
The regulatory landscape around peptides, including FDA bans and restrictions
The podcast featuring Andrew Huberman and Dr. Craig Koniver delves into the world of health-supportive compounds like NAD, methylene blue, and glycine, discussing their transformative effects on patients and exploring their applications and mechanisms.
Andrew Huberman and Craig Koniver discuss the impressive impact of NAD infusions on health, referring to the compound’s ability to enhance mitochondrial function and electrone flow, leading to substantial improvements in energy levels.
Koniver explains how NAD is related to mitochondrial health and is used in the process of making ATP, emphasizing that efficient electron flow is crucial for energy production. The discussions around NAD include its original use in the 90s for substance abuse treatment and its significant effects on patients, surpassing any other agent they have used. However, they also admit the exact biochemical mechanisms behind NAD's broad benefits are not yet fully understood.
Huberman shares his own experience with an NAD infusion during his bout with COVID, resulting in a marked improvement in symptoms and wellbeing. Koniver has seen similar transformative effects on patients with various clinical conditions. They further discuss the use of NAD infusions in specific dosages and the administration methods that have evolved during the COVID-19 pandemic, recognizing the treatment's psychological impacts and communal aspects in a clinical setting.
Methylene blue emerges as a topic of interest due to its ability to bind to cytochrome C oxidase and enhance mitochondrial efficiency and oxygen delivery, which can subsequently improve cognitive function.
The conversation touches on methylene blue's history as the first pharmaceutical prescribed in the United States and its recent resurgence as a supplement. They mention its applications, side effects, and benefits, as well as its potential antiviral properties and use as a cognitive stimulant. The compound's dosing and administration methods, including ora ...
Alternative compounds used to support health, such as NAD, methylene blue, and glycine
Download the Shortform Chrome extension for your browser